AllianceBernstein’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,280
| Closed | -$63K | – | 3394 |
|
|
2022
Q1 | $63K | Buy |
5,280
+20
| +0.4% | +$239 | ﹤0.01% | 3146 |
|
|
2021
Q4 | $171K | Sell |
5,260
-330
| -6% | -$10.7K | ﹤0.01% | 3105 |
|
|
2021
Q3 | $250K | Hold |
5,590
| – | – | ﹤0.01% | 3009 |
|
|
2021
Q2 | $305K | Buy |
5,590
+1,980
| +55% | +$108K | ﹤0.01% | 2991 |
|
|
2021
Q1 | $270K | Sell |
3,610
-800
| -18% | -$59.8K | ﹤0.01% | 2935 |
|
|
2020
Q4 | $478K | Sell |
4,410
-510
| -10% | -$55.3K | ﹤0.01% | 2610 |
|
|
2020
Q3 | $435K | Hold |
4,920
| – | – | ﹤0.01% | 2587 |
|
|
2020
Q2 | $524K | Buy |
4,920
+960
| +24% | +$102K | ﹤0.01% | 2569 |
|
|
2020
Q1 | $235K | Buy |
3,960
+910
| +30% | +$54K | ﹤0.01% | 2722 |
|
|
2019
Q4 | $211K | Buy |
3,050
+140
| +5% | +$9.69K | ﹤0.01% | 2897 |
|
|
2019
Q3 | $302K | Buy |
2,910
+840
| +41% | +$87.2K | ﹤0.01% | 2790 |
|
|
2019
Q2 | $192K | Buy |
2,070
+470
| +29% | +$43.6K | ﹤0.01% | 2976 |
|
|
2019
Q1 | $146K | Buy |
1,600
+350
| +28% | +$31.9K | ﹤0.01% | 2963 |
|
|
2018
Q4 | $70K | Hold |
1,250
| – | – | ﹤0.01% | 3021 |
|
|
2018
Q3 | $149K | Buy |
1,250
+90
| +8% | +$10.7K | ﹤0.01% | 3021 |
|
|
2018
Q2 | $118K | Buy |
+1,160
| New | +$118K | ﹤0.01% | 3028 |
|